Cholestech Announces $5.6 to $7 Million Contract With GMR Marketing to Provide Screenings for a Major Pharmaceutical Manufacturer.

Business Editors/Health & Medical Writers

HAYWARD, Calif.--(BW HealthWire)--April 19, 2001

WellCheck will provide testing services and introduce new point of

test health assessment technology

Cholestech Corporation (Nasdaq:CTEC) today announced a $5.6 to $7 million contract with GMR Marketing, naming Cholestech's subsidiary, WellCheck(TM), to provide screenings for a major pharmaceutical manufacturer in 2001. While in force, the contract provides mobile consumer testing for one year and provides for a minimum of $5.6 million in revenue, with testing not to exceed $7 million.

The agreement includes up to $5.0 million in revenue for WellCheck -- an increase of 70 to 110% over last year's programs. The contract also includes up to $1.5 million in revenue to the Company's Diagnostic Products business, and up to $500,000 in revenue to WellCheck.com. The contract provides for termination during its one-year term by either party on 30 days notice. As a key component of GMR's mobile screening program, WellCheck will provide health screening and education to consumers, including full cholesterol profiles, blood pressure, glucose testing, and cardiovascular risk assessment.

GMR's mobile screening program will be conducted by five mobile screening units throughout 2001, with a goal of testing 165,000 to 220,000 consumers in more than 25 states. WellCheck will be using its proprietary "TEAMS" technology, or Test Event Activity Management System. TEAMS automates registration, data acquisition, and information management to enhance the screening services in WellCheck programs.

"WellCheck is pleased to provide services for GMR in their mobile health education program," said Warren E. Pinckert II, president and chief executive officer of Cholestech. "GMR's choice of WellCheck as a partner shows that WellCheck continues to expand its position as a leading Health Event Specialist, capable of supporting nationwide programs in multiple disease states using cutting edge technology."

"We are significantly expanding the menu of services we are providing to GMR this year, adding new tests and technology," said Jeffrey S. Aroy, chief operating officer of WellCheck. "The nationwide implementation of our TEAMS technology will allow us to provide every participant tested with a personalized health assessment of their risk for cardiovascular disease. We also build an information warehouse of securely stored and managed data that is immediately available for use in our partners' decision support or customer relationship management activities."

"We selected WellCheck as our partner because we believe they are the leading supplier of health event services," said Gary Reynolds, chief executive officer of GMR. "Our use of WellCheck will provide great support to this important national screening program."

About GMR Marketing

GMR Marketing, an Omnicom DAS agency, is a recognized national leader in sports, mobile, music/entertainment, ethnic, and lifestyle marketing; producing major events on behalf of its diverse client roster. The agency's numerous clients include: Coleman, Kraft Foods, Mercedes, Microsoft, Miller Brewing Co., and NOKIA. Headquartered in Milwaukee, GMR also has offices in Charlotte, Chicago, Dallas, Los Angeles, New York, and San Francisco.

About Cholestech

Cholestech is committed to helping people successfully improve their health. Cholestech's business units -- Diagnostic Products, WellCheck(TM), and WellCheck.com -- combine to provide simple, accessible and reliable personal health information to consumers and health care practitioners around the world. Risk assessment and therapeutic monitoring using the Cholestech L-D-X(R) System helps reduce risk of cardiovascular disease, diabetes and liver disease. The WellCheck(TM) national testing service allows for convenient consumer testing for a number of chronic conditions, including high cholesterol, hypertension, blood sugar and osteoporosis. Consumers may enroll in WellCheck.com, a unique personal health management web site that provides interactive tools for assessing risk and monitoring progress in the management of whole-blood cholesterol levels and other lifestyle changes. Working together with health care providers, our goal is to ultimately enable people to lead longer, healthier and more active lives.

Safe Harbor Statement of Cholestech Corporation under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements as defined in the Private Securities Litigations Reform Act of 1995, including statements regarding: the successful completion of the GMR contract; actual revenues realized from the GMR contract; the proportion of revenues realized in Cholestech's subsidiaries from the GMR contract; the growth in mobile testing under the GMR contract; and the ability of TEAMS to enhance the screening experience. Actual results may differ materially from those in the forward-looking statements due to risks and uncertainties, including: those inherent in acquisitions of technologies and businesses; integration issues; unanticipated expenditures; changing relationships with customers, suppliers, and strategic partners; potential contractual, intellectual property, or employment issues; delays; the loss of a significant customer; the availability and pricing of competing products and services and the resulting effects on sales and pricing of our products and services; and other factors.

Cholestech LoDoX(R), WellCheck(TM), and WellCheck.com are registered trademarks of Cholestech Corporation. All other trademarks mentioned in this document are the property of their respective owners. For more information about Cholestech and its products visit us on the web at www.cholestech.com

WellCheck.com is available to the general public at www.wellcheck.com.